We investigatedJree gravitational bloodflow of modified packed red cells. Variables afJectingfree flow included final haematocrit, duration of blood storage at 4-6°C and the centrijilgal force required in preparation of this blood component. Irrespective of the duration ofstorageJree blood flow of modified packed red cells was not different from whole blood, provided the haematocrit did not exceed 0.63.
The need to increase plasma collection has prompted the development and introduction into clinical blood transfusion practice of modified packed red blood cells (MPRC) containing varying additive solutions. I . 3 One of the main clinical advantages of modified packed red cells over standard packed cells has been their physical resemblance to whole blood, with improved blood flow and ease of administration. The use of either dilutor-connections of the 'Y' type or of prior saline dilution of the packed cell mass has been obviated, with advantage in the surgical setting. Some of the physical advantage may be lost, however, if very high centrifugal force is used to concentrate red cells with a view to removing the maximum amount of plasma, even though the modified packed cells be supplemented with larger volumes of additive solution. The volume of plasma removed, the composition' and volume of additive solutions and the shelf age of the stored cells will either singly or in combination affect the biochemical or physical properties of the modified packed cells.
We investigated the effects of some of these variables in the preparation of modified packed red cells and related them to free (gravitational) flow through standard blood transfusion giving sets. Results indicate clearly the need to standardise the method of preparation of modified packed red cells to gain maximum acceptance in the surgical setting.
MATERIALS AND METHODS
Between 420 and 450 ml of blood was collected from each of 447 healthy voluntary donors whose red cells would as a precaution be rejected for transfusion because the donor had recently visited a geographic area where malaria is endemic. One hundred and twentythree donations were taken as whole blood into 63 ml of citrate-phosphate 227.5 mM dextrose 0.25 mM adenine anticoagulant in single packs to a total volume 493±20 ml. The haematocrits of these units were between Units taken at random were centrifuged at either 700 G for 10 minutes ('soft' spin) or 4500 G for 10 minutes ('hard' spin). Plasma was removed by gravity-siphoning into the adjoining empty pack of the circle. The volume of plasma removed was in accordance with standard protocol of the N.S.W. Red Cross Blood Transfusion Service, aiming at a final haematocrit below 0.63. The additive solution was passed to the cells, the MP RC pack detached and the contents mixed gently.
Some modified packed red cell packs taken at random were tested soon after collection. The remainder were stored between 4-6·C, and removed at random for further testing after varying time intervals.
The final storage pattern of all blood units tested is presented in Table 1 . Just prior to testing and based on the anticipated haematocrit, measured volumes of the clear supernatant (containing a mixture of additive and some residual plasma) were aspirated from the settled stored modified packed cells. The contents of the packs were then mixed gently and 5 ml aliquots removed for viscosity measurements and for haematocrit, the latter being performed in a microhaematocrit centrifuge (Gelman-Hawksley; Lancing, Sussex). Viscosities were measured in a Brookfield viscosimeter. The tests were done at 22·C at low shear rates of 23 s -1 with no attempt made to either dilute, wash or pre-filter the stored specimen. With progressive storage-dependant fall in erythrocyte deformability, high haematocrit and associated micro-or macroaggregate formation, 4 it was not possible to obtain reproducible viscosity measurements on all aliquots (particularly at high shear rates) and the data are not presented in this paper. Table 2 lists numbers of units and their final haematocrit prior to flow time tests.
The blood flow was measured in minutes by timing the period required for the pack to empty when blood was passed by gravity through a standard blood transfusion giving set incorporating 1 70 ~mesh filter (TUT A Laboratories, Lane Cove, Sydney). The set terminated in a steel blood transfusion needle, 375 mm long, external diameter 1.0 mm, bore 0.65 mm (TUT A Laboratories, Lane Cove, Sydney). The packs were suspended one metre above a bucket and the valve on the giving set opened fully. No added pressure was applied to the bags. As many as ten bags were examined in batches and some reached 20·C by completion of testing.
The association of flow time with final haematocrit, G force, storage period and volume of supernate removed was assessed by multiple linear regression. In order to give a normal distribution the flow time was transformed to its reciprocal before analysis, that is, the variable analysed was flow speed, but the results are presented in terms of flow time. Figure 1 shows that the flow times increased significantly with both haematocrit and progression of shelf life (P < 0.001). After Figure I , the flow times of these modified packed red cells do not differ from those of whole blood. 
RESULTS

DISCUSSION
Previously, and particularly in surgical settings, it was difficult to motivate clinicians to use the packed cells, partly because they often required additional manipulations by either insertion of a Y set connector to a saline bag or pre-dilution with saline. One of the main reasons for the ready and now often preferential use of modified packed red cells in clinical practice has been their acceptable blood flow at the bedside. The usage of modified packed red cells now is about 80% of total blood collected, compared with less than 25% as packed cells some ten years ago. It may be possible to improve on 80% acceptance with benefit to the pool of plasma available for fractionation.
Currently, 85% of requirements in adult transfusion practice, surgery included, are met with approximately three units of blood. With only three units of blood as replacement therapy, most of the patient's needs would be met with modified packed red cells alone, provided the free gravitational blood flow were acceptable. 5 The data presented shows that acceptance will depend on close attention to such variables as the final haematocrit, shelf life of the unit, and to a lesser extent the ratio of the mixture of additive and plasma remaining in the modified packed cells. Because of the need for maximal plasma harvesting some blood transfusion services are issuing modified packed cells from which almost all plasma has been removed. The volume of additive may be increased from 63 ml to 100 ml to compensate but it is clear that modified packed red cells with haematocrit in excess of 0.63 will result in a clinically unacceptable blood flow at the bedside. Furthermore, inferior flow times tend to worsen with the progression of shelf life. Literature provides only scant data about free flowing packed cells, modified packed red cells and whole blood,6.7 but in general such information is in agreement with the results of the present study.
In this Blood Transfusion Service the quality assurance unit closely monitors properties of the modified packed red cells. For instance, the last six months' production of hard-spun modified packed red cells averaged 306 (SO 32) ml/pack with haematocrit 0.57 (SD 0.03). The soft-spun modified packed cells recorded volumes of 340 (SD 26) ml and haematocrit 0.54 (SD 0.02).
It is noteworthy that in the experiments, flow times increased not only with storage time and haematocrit but also with the volume of supernate removed. By inference this involves also the degree of initial plasma removal. Unfortunately the experimental design of the study did not allow this variable to be tested directly as the modified packed red cells were stored with haematocrit not exceeding 0.63 until the flow-time experiments. When modified packed red cells with a haematocrit above 0.85 are stored beyond 21 days, unsatisfactory physical ,4 biochemical and 24 hour autologous posttransfusion survivals 8 are on record.
If leaving some plasma in the packed cells improved flow times of the modified packed red cells, then not much would be gained by increasing the volume of additive to compensate for complete plasma removal. It appears that leaving some quantity of plasma in the packed cells improves flow time of the modified packed red cells and that nothing is gained by increasing the volume of additive to compensate for complete plasma removal. There is no satisfactory explanation for this phenomenon, but it may serve as another useful guide when standardising the preparation of modified packed cells.
In conclusion, this investigation clearly indicates the need for standardisation of modified packed red cells if their clinical acceptance is to be improved. The tendency of some blood banks to maximise plasma harvesting and release modified packed red cells with a haematocrit in excess of 0.63 after prolonged storage may be inappropriate for routine transfusional support. Although maximum plasma harvesting is currently the primary target of all blood transfusion services, supplying clinically unacceptable packed cell residues could bring about a reversion to preferential use of whole blood and thus be counterproductive.
